NEWS IN BRIEF

Nimble leaves Roche to commercialize chemical synthesis technology

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Caiaimage/MartinBarraud)
(Image: Getty/Caiaimage/MartinBarraud)

Related tags: Roche, Chemical synthesis, Technology, Commercialization, Drug discovery, Drug development, Drug development process

Nimble Therapeutics spun out from parent company Roche to commercialize its chemical synthesis technology for drug discovery and development.

Nimble will operate as an independent business after Roche spun out the company and will look to establish strategic partnerships to jointly develop ‘unique’ drug candidates across various therapeutic areas, according to CEO, Jigar Patel.

Roche acquired Nimble​, then NimbleGen, in a $272.5m (€203m) deal in 2007. The Roche team that helped develop the chemical synthesis technology will join the fully independent company.

Board director at Nimble, Deval Lashkari, said in a statement, “The Roche team saw the value in separating the business to enable it to expand its platform and work on a variety of therapeutic areas with strategic partners.”

According to Nimble, the chemical synthesis technology platform can synthesize ‘millions’ of unique natural and modified peptide-based molecules.

Based in Madison, Wisconsin, Nimble has also developed biological assays that can be used for empirical optimization of molecules.

Related news

Related products

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers

Follow us

Products

View more